A Phase 1 Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases (BRAINSTORM)
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2018
Price : $35 *
At a glance
- Drugs RRx 001 (Primary)
- Indications Brain metastases
- Focus Adverse reactions
- Acronyms BRAINSTORM
- Sponsors EpicentRx
- 04 Jun 2018 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.
- 04 Jun 2018 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2018.
- 02 Jul 2017 Status changed from recruiting to active, no longer recruiting.